Showing Results for
- Academic Journals (660)
Search Results
- 660
Academic Journals
- 660
-
From:Pharmacogenomics (Vol. 14, Issue 13) Peer-ReviewedAuthor(s): Gregorio Antonio Alcazar-González 1 , Ana Laura Calderón-Garcidueñas 2 , María Lourdes Garza-Rodríguez 3 , Gabriela Rubio-Hernández 4 , Sergio Escorza-Treviño 5 , Estibaliz Olano-Martin 6 , Ricardo Martín...
-
From:Reactions Weekly (Issue 1337)Postmenopausal women with early breast cancer are 26% more likely to develop heart disease when treated with an aromatase inhibitors (AI) than when treated with tamoxifen, according to the results of a meta-analysis...
-
From:Women's Health (Vol. 5, Issue 1) Peer-ReviewedWomen who are diagnosed with breast cancer are prescribed tamoxifen for a period of 5 years in order to prevent the disease from returning. However, some patients develop resistance to the drug, meaning that there is a...
-
From:Personalized Medicine (Vol. 4, Issue 1) Peer-ReviewedAuthor(s): Sudhir Srivastava [[dagger]] 1 , Paul D Wagner 1 Keywords: biomarkers; cancer; oncogenes; raloxifene; risk assessment; tamoxifen; tumor suppressor genes Successful application of personalized...
-
From:Family Practice News (Vol. 37, Issue 2)SAN ANTONIO -- Lumpectomy and tamoxifen without radiotherapy is a reasonable choice for women aged 70 years or older with early-stage estrogen receptor-positive breast cancer, Dr. Kevin S. Hughes said at a breast cancer...
-
From:Clin Alert (Vol. 44, Issue 14)No. 196 A 74-year-old female patient with a history of breast cancer developed decreased vision in both eyes approximately 4 years after starting tamoxifen (20 mg daily). She received a total dose of 36.5 g of...
-
From:Cancer Nursing Practice (Vol. 5, Issue 9) Peer-ReviewedThanks to a new recommendation by the National Institute for Health and Clinical Excellence (NICE), the thousands of women who are diagnosed with hormone receptor-positive breast cancer each year in the UK could be...
-
From:Family Practice News (Vol. 33, Issue 8)EXETER, ENGLAND -- Acupuncture was associated with a reduction in the frequency and severity of hot flashes in women being treated with tamoxifen for breast cancer. In a pilot study, 47 women with a primary diagnosis...
-
From:British Medical Journal (Vol. 304, Issue 6833) Peer-ReviewedTamoxifen alone is no longer justified Over one third of all breast cancers occur in women over 70. Although these elderly women have often been excluded from breast cancer trials, women aged 70 have a life...
-
From:Science (Vol. 270, Issue 5242) Peer-ReviewedReanalysis of the results of a study of more than 2,000 breast cancer patients supported the initial conclusion that lumpectomy is as effective mastectomy in treating the disease. The reanalysis of the B-06 study was...
-
From:Journal of Reproduction and Infertility (Vol. 20, Issue 1) Peer-ReviewedBackground: Tamoxifen (TX) is widely used to treat idiopathic infertility in men. Using TX has been shown to produce sperm in patients with oligospermia and azoospermia and improve male fertility. The aim of this study...
-
From:Practice Nurse (Vol. 36, Issue 9)Breast cancer patients are risking their lives by failing to take the tamoxifen they are prescribed, a study has found. Researchers from the University of Dundee found that half of the women they followed failed to...
-
From:Stem Cell Research & Therapy (Vol. 12, Issue 1) Peer-ReviewedBackground Radiation-induced rectal epithelial damage is a very common side effect of pelvic radiotherapy and often compromise the life quality and treatment outcome in patients with pelvic malignancies. Unlike small...
-
From:Hereditary Cancer in Clinical Practice (Vol. 2) Peer-ReviewedOptions for the prevention of hereditary breast and ovarian cancer include screening, preventive surgery and chemoprevention. Screening studies with magnetic resonance imaging of the breast are promising but the...
-
From:Psychiatric Times (Vol. 37, Issue 8) Peer-ReviewedWhat happens at the molecular level in patients after they ingest a medication? Over the past 30 years, psychiatry has come a long way, especially in better understanding the importance of considering the cytochrome P450...
-
From:Expert Review of Anticancer Therapy (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Emmanuel M Gabriel 1 , Ismail Jatoi [**] 2 Keywords : breast cancer; chemoprevention; exemestane; raloxifene; tamoxifen There have been several large randomized clinical trials investigating the...
-
From:Pharmacogenomics (Vol. 13, Issue 6) Peer-ReviewedAuthor(s): William G Newman 1 , Dave Flockhart [**] 2 KEYWORDS : aromatase inhibitors; breast cancer; CYP2D6; pharmacogenetics; tamoxifen There is perhaps no field of therapeutics in which personalized...
-
From:Dermatology Nursing (Vol. 21, Issue 4) Peer-ReviewedAutoimmune progesterone dermatitis (APD) is a rare disorder characterized by recurrent skin manifestations starting during the luteal phase of a woman's menstrual cycle. Risk factors include fertile women with a...
-
From:Reactions Weekly (Issue 1300)[S] A 76-year-old woman developed late-onset hypoxaemia and severe exertional dyspnoea during tamoxifen therapy for breast carcinoma [dosage and duration of treatment to reaction onset not stated]. A chest CT scan...
-
From:Family Practice News (Vol. 37, Issue 17)CHICAGO -- Hot flashes may be an indicator of the efficacy of adjuvant tamoxifen therapy in women who have completed breast cancer treatment, a new study suggests. Data from a large prospective trial of breast cancer...